Ambalwa ama-hormone asuke ezincwadini ze-physiology ezingacacile angena engxoxweni evamile ngokushesha njenge-glucagon-like peptide-1 (GLP-1). Eqhutshwa kakhulu ukuthandwa kwama-agonists e-GLP-1 receptor agonists emithi, intshisekelo yabathengi "ekusekelweni kwe-GLP-1" ikhule ngokushesha yaya endaweni yokudla, iziphuzo, kanye nezithasiselo.
Kuyini i-GLP-1?
I-GLP-1 iyi-hormone ye-peptide ekhishwa amaseli e-L olwelwesini lwamathumbu ngenxa yokudla okunomsoco, ikakhulukazi ngemva kokudla okuqukethe amaprotheni, amafutha, kanye ne-fibre. Iyingxenye yeqembu lama-hormone aziwa ngokuthi ama-incretins, ahlanganisa ukugaya nokusabalalisa kwe-metabolic. Uma ikhishwe, i-GLP-1 isebenza kuma-receptor asakazwe kuwo wonke ama-pancreas, isibindi, ubuchopho, amathumbu kanye nezicubu zamafutha, okwenza ibe nethonya ezinhlelweni eziningana ezixhumene kunokuba ibe yindlela eyodwa (Lotosky et al., 2025).
Ku-pancreas, i-GLP-1 ithuthukisa ukukhishwa kwe-insulin futhi isekela ukusebenza kwamaseli e-beta. Ebuchosheni, isebenzisana nezikhungo zesifiso sokudla ukuze ikhuthaze ukusutha nokunciphisa ukuziphatha kokufuna ukudla. Emathunjini, yehlisa ukuphelelwa yisisu, okwandisa umuzwa wokugcwala ngemva kokudla. Izenzo zayo esibindini nasemisipha yamathambo, okuhlanganisa nokusekela ukwenziwa kwe-glycogen kanye nokusetshenziswa kwamandla, zisabonakala kodwa zibhekwa njengezibalulekile emiphumeleni yayo ebanzi ye-metabolic (Lotosky et al., 2025).
Funda futhi: Izinzuzo ze-Milk Thistle yesibindi kanye noshukela wegazi
Ngenxa yokuthi i-GLP-1 iqhekeka ngokushesha emzimbeni yi-enzyme dipeptidyl peptidase-4 (DPP-4), ifasitela layo lemvelo lokubonisa izimpawu lifushane. Lesi ngesinye sezizathu ezenza ukuba ama-agonist e-GLP-1 receptor agonists athuthukiswe ngezakhiwo eziguquliwe ezimelana nokuwohloka kwe-DPP-4 (Lotosky et al., 2025).
Yingakho futhi abacwaningi bezokudla okunempilo benesithakazelo ezithakweni ezingase zisekele umsebenzi we-GLP-1 womzimba, kungaba ngokukhuthaza ukukhishwa kwawo noma ngokuvimbela i-enzyme eyiphulayo.
Indima ye-GLP-1 ekulawulweni kokudla
Isifiso sokudla asilawulwa yisignali eyodwa kodwa yinethiwekhi yokuxhumana kwamathumbu nobuchopho, lapho i-GLP-1 idlala indima yokuxhumanisa. Ngemva kokudla, amazinga aphezulu e-GLP-1 anegalelo ekunciphiseni indlala, ukuphelelwa ngamandla kwesisu, kanye nokwanda kwemizwa yokugcwala. Le nhlanganisela isiza ukuchaza ukuthi kungani i-GLP-1 isibe yinto ebalulekile ocwaningweni lokulawula isisindo, kokubili kwezokwelapha kanye nokudla okunempilo. Okubalulekile, i-GLP-1 ayisebenzi yodwa; isebenzisana namanye ama-hormone amathumbu, kufaka phakathi i-ghrelin kanye ne-peptide YY, njengengxenye yesistimu ebanzi yokulawula isifiso sokudla.
Umsebenzi we-GLP-1 kanye neMetabolic
Ngaphandle kwesifiso sokudla, ukubonakaliswa kwe-GLP-1 okuhlobene nokusetshenziswa kwe-glucose kuye kwaxhunyaniswa nokulawulwa kwe-glucose, i-lipid metabolism, kanye nokusetshenziswa kwamandla. Ezicutshini zesibindi, i-GLP-1 isekela ukwakheka kwe-glycogen ngezindlela ezincike ku-insulin kanye nezindlela ezingaba khona zokungasebenzisi i-insulin. Ezicutshini ze-adipose, i-GLP-1 ibikwe ukuthi ikhuthaza i-thermogenesis yezicubu ze-adipose ezinsundu kanye nokusetshenziswa kwamandla, indlela ebhekwa njengefanele ukwehla kwesisindo ehlotshaniswa nemithi yokwelapha ye-GLP-1 receptor agonist (Lotosky et al., 2025).
Lezi zindlela zisalokhu ziyindawo esebenzayo yokucwaninga, futhi izikhala zolwazi ezibalulekile ziyavunywa ezincwadini, ikakhulukazi maqondana nobungako bemiphumela eqondile ye-GLP-1 ezicutshini ezithile.
Funda futhi: Izithasiselo ze-Liposomal: Isikhathi Esisha Sokumuncwa Kwezakhamzimba
Izindlela Zezitshalo Zokusekela Izindlela Ze-GLP-1
Ucwaningo olukhulayo lwezokudla okunempilo luhlole ukuthi izingcezu ezithile ezithathwe ezitshalweni zingathinta yini umsebenzi we-GLP-1 wangaphakathi, kungaba ngokuvuselela ukukhishwa kwayo emathunjini noma ngokulinganisela umsebenzi we-DPP-4, i-enzyme ebangela ukuwohloka okusheshayo kwe-GLP-1. Intshisekelo kule ndawo iye yashesha kanye nengxoxo ebanzi ye-GLP-1, lapho abakhiqizi bebheka kakhulu izindlela ezisekelwe ekudleni ezisebenza ngendlela efanayo ye-incretin njengezokwelapha ze-GLP-1 zemithi, ngaphandle kokuba yimikhiqizo yemithi ngokwayo.
Isibonelo esisodwa esivela kuphothifoliyo ye-NaturMed Scientific yi-Theolim, inhlanganisela ejwayelekile, enelungelo lobunikazi yezinhlamvu ze-Key lime (Citrus aurantifolia) kanye ne-cocoa (Theobroma cacao) . Kuhlelo oluhleliwe locwaningo lwangaphambi kokwelashwa kanye nolwezokwelapha, i-Theolim ihlolwe ngemiphumela yayo ekusetshenzisweni kwamandla, ukwakheka komzimba, kanye nezimpawu ezihlobene nokuguqulwa kwe-metabolic. Kumamodeli eseli nezilwane, inhlanganisela yabonwa ukusekela ukubonakaliswa kwamaprotheni ahlotshaniswa nomsebenzi we-thermogenic, okuhlanganisa ukuhlukanisa iphrotheni-1 kanye ne-beta-3 adrenergic receptor, ngezinga elikhulu kunanoma iyiphi i-source extract yodwa (Kundimi et al., 2024).
Ucwaningo lwabantu seluqhubekele phambili kusukela esivivinyweni esiphuthumayo se-crossover, lapho izinga lokuphumula kwe-metabolic kanye ne-oxidation yamafutha kwakuphakeme kakhulu ngemuva komthamo owodwa uma kuqhathaniswa ne-placebo (Ammatalli et al., 2024), kwaze kwaba sesivivinyweni esingahleliwe, esingaboni kabili, esilawulwa yi-placebo samasonto ayi-16 kubantu abadala abakhuluphele abangu-120.
Funda futhi: Izithako Ezinophawu
Kulolo vivinyo lwamasonto ayi-16, ukwengezwa kwe-Theolim kwahlotshaniswa nokwehla okukhulu kwesisindo somzimba kanye nesisindo samafutha uma kuqhathaniswa ne-placebo, kanye nokwanda okumaphakathi okungu-33% ku-serum GLP-1 kusukela ekuqaleni esontweni le-16, ukwehla okukhulu ku-ghrelin, kanye nokuthuthuka kuma-lipid akhethiwe kanye nama-insulin-sensitivity markers (Chadalavada et al., 2025). Lokhu kusalokhu kungenye yezingcezu ezibalulekile zobufakazi babantu kuze kube manje ezixhumanisa inhlanganisela yezitshalo esuselwa ekudleni nomsebenzi we-GLP-1 wangaphakathi, yize ukuphindaphindwa okuzimele kanye nokucaciswa okwengeziwe kwezinguquko ze-biomarker kuzoqinisa isisekelo sobufakazi.
Umongo kanye nemikhawulo
Nakuba le ndawo yocwaningo ikhula ngokushesha, kufanele kuqashelwe izixwayiso eziningana. Ubufakazi obuningi bokusebenza obuxhumanisa izithako zezitshalo nomsebenzi we-GLP-1 buqala kumamodeli eseli nezilwane, angenakuqondwa ngqo emiphumeleni yabantu futhi aqondwa kangcono njengokuqala. Ucwaningo lwe-Botanical GLP-1 alunandisi ububanzi bezimangalo zomsebenzi wesakhiwo ezivunyelwe zezithako zokudla ezindaweni eziningi zokulawula; nokho, lungaqinisa isizathu sesayensi esiyisisekelo sezimangalo ezikhona mayelana nokwaneliseka, ukulawulwa kwesifiso sokudla, kanye nempilo ye-metabolic. Abakhiqizi kanye nemikhiqizo bakhuthazwa ukuthi babeke ucwaningo lwezitshalo oluhlobene ne-GLP-1 njengengxenye eyodwa yendaba ebanzi yezempilo ye-metabolic, kunokuba kube yindawo eqondile yokudla okunempilo yemithi kadokotela ye-GLP-1.
Qaphela: Izithako kanye nezifundo okuxoxwe ngazo kulesi sihloko ziyizithako zokudla, hhayi imikhiqizo yezokwelapha enelayisensi, futhi azihloselwe ukuxilonga, ukwelapha, ukwelapha, noma ukuvimbela noma yisiphi isifo. Abathengi abanezinkinga zempilo ezikhona noma labo abathatha imithi, okuhlanganisa nemithi ye-GLP-1 receptor agonist, bayelulekwa ukuthi babonisane nochwepheshe wezempilo ofanelekayo ngaphambi kokusebenzisa.
Okubhekwayo
U-Ammatalli, NKR, Kuricheti, SSSK, Veeramachaneni, S., Koo, YK, Ramanathan, G. kanye no-Yalamanchi, A. (2024) 'Inhlanganisela ye-Citrus aurantifolia fruit pend kanye ne-Theobroma cacao seed extracts supplement ithuthukisa amazinga e-metabolic kubantu abakhuluphele ngokweqile: ucwaningo olungahleliwe, olulawulwa yi-placebo, oluhlanganisa wonke umuntu', i-Food & Nutrition Research, 68, isihloko 10745. Itholakala ku: https://doi.org/10.29219/fnr.v68.10745
UChadalavada, A., Koo, YK, Kim, S., Veeramachaneni, S., Ramanathan, G. kanye noYalamanchi, A. (2025) 'Ukwakheka kwezitshalo okuhambisana ne-thermogenic okuqukethe i-Citrus aurantifolia fruit pend kanye ne-Theobroma cacao seed extracts kuthuthukisa ukwakheka komzimba kubantu abadala abakhuluphele ngokweqile: uphenyo lwezokwelapha', Food & Nutrition Research, 69, isihloko 12159. Kutholakala ku: https://doi.org/10.29219/fnr.v69.12159
Kundimi, S., Chinta, G., Alluri, KV, Golakoti, T., Veeramachaneni, S., Ramanathan, G. kanye noSengupta, K. (2024) 'Ukwakheka kwezitshalo okuhambisanayo kwandisa ukusetshenziswa kwamandla okuphumula futhi kunciphisa ukukhuluphala kwamagundane adla ukudla okunamafutha amaningi', i-Journal of the American Nutrition Association, 43(3), amakhasi 286–295. Itholakala ku: https://doi.org/10.1080/27697061.2023.2280777
ULotosky, J., uJean, X., u-Altankhuyag, A., uKhan, S., uBernotas, A., uSharafshah, A., uBlum, K., uPosner, A. noThanos, PK (2025) 'I-GLP-1 kanye nendima yayo ekukhiqizweni kwe-glycogen: isibuyekezo esilandisayo', i-Biomedicines, 13(7), isihloko 1610. Itholakala ku: https://doi.org/10.3390/biomedicines13071610
Isixwayiso: Lesi Sitatimende asikahlolwa yi-EFSA, i-KFDA noma i-FDA. Lo mkhiqizo awuhloselwe ukuxilonga, ukwelapha, ukwelapha, noma ukuvimbela noma yisiphi isifo. Nakuba ulwazi olunikeziwe lusekelwe ezinkombeni ezithembekile, asenzi noma yiziphi izimangalo noma iziqinisekiso ezithile. Kubalulekile ukubonisana nomeluleki wakho wezempilo ukuze uthole iseluleko nesiqondiso esiqondene nawe esiphathelene nempilo yakho.
